Schedule 13G ownership disclosure

SCPHARMACEUTICALS INC

Common stock, par value $0.0001 per share · CUSIP: 810648105

Event date: 2025-09-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Glazer Capital, LLC

    Shares: 2,474,820.00 · Class: 4.64%

  • Paul J. Glazer

    Shares: 2,474,820.00 · Class: 4.64%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001076809-25-000106
Form type
SCHEDULE 13G
Filer
GLAZER CAPITAL, LLC
CIK
CIK 1076809
Filed
Sep 10, 2025
Reporting period
Sep 02, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub